| Tablets | |||||
| Sr.No. | Brand Name | Composition | |||
| 1 | Cefixime Tablets I.P. | Each Film Coated Tablets contains: | |||
| Cefixime | I.P. | 50 | mg | ||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 2 | Cefixime Tablets I.P. | Each Film Coated Tablets contains: | |||
| Cefixime | I.P. | 100 | mg | ||
| Eq. to Anhydrous Cefixime | Q.S. | ||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 3 | Cefixime Tablets I.P. | Each Film Coated Tablets contains: | |||
| Cefixime | I.P. | 200 | mg | ||
| Eq. to Anhydrous Cefixime | Q.S. | ||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 4 | Cefpodoxime Tablets I.P. | Each Film Coated Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 200 | mg | ||
| Eq. to Cefpodoxime | Q.S. | ||||
| Excipients:Colour : Approved Colour Used | |||||
| 5 | Cefuroxime Tablets I.P. | Each Film Coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 250 | mg | ||
| Eq. to Anhydrous Cefuroxime | Q.S. | ||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 6 | Cefuroxime Tablets I.P. | Each Film Coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 500 | mg | ||
| Eq. to Anhydrous Cefuroxime | Q.S. | ||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 7 | Amoxycillin & Potassium Clavulanate Tablets I.P. | Each Film Coated Tablets contains: | |||
| Amoxycillin Trihydrate | I.P. | 500 | mg | ||
| Eq. to Amoxycillin | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 8 | Amoxycillin Dispersible Tablets I.P. | Each Dispersible Tablets contains: | |||
| Amoxycillin Trihydrate | I.P. | 125 | mg | ||
| Eq.to Amoxycillin | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| 9 | Amoxycillin Dispersible Tablets I.P. | Each Dispersible Tablets contains: | |||
| Amoxycillin Trihydrate | I.P. | 250 | mg | ||
| Eq.to Amoxycillin | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| 10 | Ampicillin Dispersible Tablets I.P. | Each Dispersible Tablets contains: | |||
| Ampicillin Trihydrate | I.P. | 125 | mg | ||
| Eq. to Ampicillin | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| 11 | Ampicillin Dispersible Tablets I.P. | Each Dispersible Tablets contains: | |||
| Ampicillin Trihydrate | I.P. | 250 | mg | ||
| Eq. to Ampicillin | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| 12 | Amoxycillin & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Amoxycillin Trihydrate | I.P. | 250 | mg | ||
| Eq. to Amoxycillin | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 13 | Amoxycillin & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Amoxycillin Trihydrate | I.P. | 875 | mg | ||
| Eq. to Amoxycillin | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 14 | Amoxycillin & Potassium Clavulanate Dispersible Tablets | Each Dispersible Tablets contains: | |||
| Amoxycillin Trihydrate | I.P | 250 | mg | ||
| Eq. to Amoxycillin | I.P. | 150 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | Q.S. | ||||
| Excipients: | |||||
| Flavoured Base: | |||||
| Colour: Approved Colour Used | |||||
| 15 | Ampicillin & Dicloxacillin Tablets | Each Film Coated Tablets contains: | |||
| Ampicillin Trihydrate | I.P | 250 | mg | ||
| Eq. to Amoxycillin | I.P. | 250 | mg | ||
| Dicloxacillin Sodium | Q.S. | ||||
| Eq. to Dicloxacillin | |||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 16 | Cefadroxil Tablets I.P. | Each Uncoated Tablets contains: | |||
| Cefadroxil Monohydrate | I.P. | 500 | mg | ||
| Eq. to Cefadroxil | Q.S. | ||||
| Excipients: | |||||
| Colour :Approved Colour Used | |||||
| 17 | Cefadroxil Tablets I.P. | Each Uncoated Tablets contains: | |||
| Cefadroxil Monohydrate | I.P. | 1000 | mg | ||
| Eq. to Cefadroxil | Q.S. | ||||
| Excipients: | |||||
| Colour :Approved Colour Used | |||||
| 18 | Cephalexin Tablets I.P. | Each Film coated Tablets contains: | |||
| Cephalexin | I.P. | 250 | mg | ||
| Eq. to Cephalexin Anhydrous | Q.S. | ||||
| Excipients: | |||||
| Colour :Approved Colour Used | |||||
| 19 | Cephalexin Tablets I.P. | Each Film coated Tablets contains: | |||
| Cephalexin | I.P. | 500 | mg | ||
| Eq. to Cephalexin Anhydrous | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| Colour :Approved Colour Used | |||||
| 20 | Cefpodoxime Tablets I.P. | Each Film coated Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 50 | mg | ||
| Eq. to Cefpodoxime | Q.S. | ||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 21 | Cefpodoxime Tablets I.P. | Each Film coated Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 100 | mg | ||
| Eq. to Cefpodoxime | Q.S. | ||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 22 | Cefpodoxime Tablets I.P. | Each Film coated Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 200 | mg | ||
| Eq. to Cefpodoxime | Q.S. | ||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 23 | Cefuroxime Tablets I.P. | Each Film coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 125 | mg | ||
| Eq. to Cefuroxime Anhydrous | Q.S. | ||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 24 | Cefaclor Prolonged Release Tablets I.P. | Each Film coated Tablets contains: | |||
| Cefaclor Monohydrate | I.P. | 125 | mg | ||
| Eq. to Cefaclor | Q.S. | ||||
| Excipients | Q.S. | ||||
| Colour: Approved Colour Used | |||||
| 25 | Cefaclor Prolonged Release Tablets I.P. | Each Film coated Tablets contains: | |||
| Cefaclor Monohydrate | I.P. | 250 | mg | ||
| Eq. to Cefaclor | Q.S. | ||||
| Excipients | Q.S. | ||||
| Colour: Approved Colour Used | |||||
| 26 | Cefixime & Potassium Clavulanate Tablets | Each Film coated Tablets contains: | |||
| Cefixime | I.P. | 200 | mg | ||
| Eq. to Cefixime Anhydrous | Q.S. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 27 | Cefixime & Potassium Clavulanate Tablets | Each Film coated Tablets contains: | |||
| Cefixime | I.P. | 100 | mg | ||
| Eq. to Cefixime Anhydrous | Q.S. | 62.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 28 | Cefixime & Potassium Clavulanate Tablets | Each Film coated Tablets contains: | |||
| Cefixime | I.P. | 50 | mg | ||
| Eq. to Cefixime Anhydrous | Q.S. | 31.25 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 29 | Cefixime & Ofloxacin Tablets | Each Film coated Tablets contains: | |||
| Cefixime | I.P. | 100 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 100 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients | |||||
| Colour: Approved Colour Used | |||||
| 30 | Cefixime & Ofloxacin Tablets | Each Film coated Tablets contains: | |||
| Cefixime | I.P. | 200 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 200 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients | |||||
| Colour: Approved Colour Used | |||||
| 31 | Cefixime & Ofloxacin Sustained Release Tablets | Each Sustained Release Tablets contains: | |||
| Cefixime | I.P. | 200 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 200 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients | |||||
| Colour: Approved Colour Used | |||||
| 32 | Cefixime & Ofloxacin Sustained Release Tablets | Each Sustained Release Tablets contains: | |||
| Cefixime | I.P. | 400 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 400 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients | |||||
| Colour: Approved Colour Used | |||||
| 33 | Cefixime & Ofloxacin Dispersible Tablets | Each Uncoated Dispersible Tablets contains: | |||
| Cefixime | I.P. | 100 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 100 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients | |||||
| Flavoured Base | |||||
| Colour: Approved Colour Used | |||||
| 34 | Cefixime & Ofloxacin Dispersible Tablets | Each Uncoated Dispersible Tablets contains: | |||
| Cefixime | I.P. | 200 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 200 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients | |||||
| Flavoured Base | |||||
| Colour: Approved Colour Used | |||||
| 35 | Cefixime & Moxifloxacin Sustained Release Tablets | Each Sustained Release Tablets contains: | |||
| Cefixime (S.R.) | I.P. | 400 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 400 | mg | ||
| Moxifloxacin HCl (S.R.) | Q.S. | ||||
| Eq. to Anhydrous Moxifloxacin ( | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 36 | Cefpodoxime & Ofloxacin Dispersible Tablets | Each Uncoated Dispersible Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 100 | mg | ||
| Eq. to Cefpodoxime | I.P. | 100 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients: | |||||
| Flavoured Base | |||||
| Colour: Approved Colour Used | |||||
| 37 | Cefpodoxime & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 200 | mg | ||
| Eq. to Cefpodoxime | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients | |||||
| Colour: Approved Colour Used | |||||
| 38 | Cefpodoxime & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 100 | mg | ||
| Eq. to Cefpodoxime | I.P. | 62.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients | |||||
| Colour: Approved Colour Used | |||||
| 39 | Cefpodoxime & Potassium Clavulanate Dispersible Tablets | Each Uncoated Dispersible Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 100 | mg | ||
| Eq. to Cefpodoxime | I.P. | 62.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Flavoured Base: | |||||
| Colour: Approved Colour Used | |||||
| 40 | Cefpodoxime & Potassium Clavulanate Dispersible Tablets | Each Uncoated Dispersible Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 50 | mg | ||
| Eq. to Cefpodoxime | I.P. | 31.25 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Flavoured Base: | |||||
| Colour: Approved Colour Used | |||||
| 41 | Cefuroxime & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 250 | mg | ||
| Eq.to Anhydrous Anhydrous | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 42 | Cefuroxime & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 125 | mg | ||
| Eq. to Cefuroxime Anhydrous | I.P. | 62.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 43 | Cefuroxime & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 250 | mg | ||
| Eq. to Cefuroxime Anhydrous | I.P. | 62.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 44 | Cefuroxime & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 500 | mg | ||
| Eq. to Cefuroxime Anhydrous | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||